335 related articles for article (PubMed ID: 3928681)
21. Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum.
Steenbergen JN; Nosanchuk JD; Malliaris SD; Casadevall A
Infect Immun; 2003 Sep; 71(9):4862-72. PubMed ID: 12933827
[TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase and CO2 sensing during Cryptococcus neoformans growth, differentiation, and virulence.
Bahn YS; Cox GM; Perfect JR; Heitman J
Curr Biol; 2005 Nov; 15(22):2013-20. PubMed ID: 16303560
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of complement-mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirect C3-mediated interactions.
Zaragoza O; Taborda CP; Casadevall A
Eur J Immunol; 2003 Jul; 33(7):1957-67. PubMed ID: 12884862
[TBL] [Abstract][Full Text] [Related]
24. Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses.
Collins HL; Bancroft GJ
Infect Immun; 1991 Nov; 59(11):3883-8. PubMed ID: 1937747
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization and evaluation of virulence factors of Cryptococcus laurentii and Cryptococcus neoformans strains isolated from external hospital areas.
Andrade-Silva L; Ferreira-Paim K; Silva-Vergara ML; Pedrosa AL
Fungal Biol; 2010; 114(5-6):438-45. PubMed ID: 20943154
[TBL] [Abstract][Full Text] [Related]
26. Induction of capsule growth in Cryptococcus neoformans by mammalian serum and CO(2).
Zaragoza O; Fries BC; Casadevall A
Infect Immun; 2003 Nov; 71(11):6155-64. PubMed ID: 14573631
[TBL] [Abstract][Full Text] [Related]
27. [Ultrastructural Patterns of Interactions between Murine Lung Macrophages and Yeast Cells of Cryptococcus neoformans Strains with Different Virulence].
Stepanova A; Vasilyeva N; Yamaguchi M; Chibana H; Bosak I; Filippova L
Med Mycol J; 2018; 59(1):E1-E6. PubMed ID: 29491337
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic Variability Correlates with Clinical Outcome in
Fernandes KE; Brockway A; Haverkamp M; Cuomo CA; van Ogtrop F; Perfect JR; Carter DA
mBio; 2018 Oct; 9(5):. PubMed ID: 30352938
[TBL] [Abstract][Full Text] [Related]
29. Decreased virulence in stable, acapsular mutants of cryptococcus neoformans.
Fromtling RA; Shadomy HJ; Jacobson ES
Mycopathologia; 1982 Jul; 79(1):23-9. PubMed ID: 6750405
[TBL] [Abstract][Full Text] [Related]
30. Difference in Cryptococcus neoformans cellular and capsule size in sequential pulmonary and meningeal infection: a postmortem study.
Xie S; Sao R; Braun A; Bottone EJ
Diagn Microbiol Infect Dis; 2012 May; 73(1):49-52. PubMed ID: 22424901
[TBL] [Abstract][Full Text] [Related]
31. The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding.
Zaragoza O; Telzak A; Bryan RA; Dadachova E; Casadevall A
Mol Microbiol; 2006 Jan; 59(1):67-83. PubMed ID: 16359319
[TBL] [Abstract][Full Text] [Related]
32. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.
Kozel TR
Infect Immun; 1983 Mar; 39(3):1214-9. PubMed ID: 6341232
[TBL] [Abstract][Full Text] [Related]
33. Phagocytosis of Cryptococcus neoformans by, and nonlytic exocytosis from, Acanthamoeba castellanii.
Chrisman CJ; Alvarez M; Casadevall A
Appl Environ Microbiol; 2010 Sep; 76(18):6056-62. PubMed ID: 20675457
[TBL] [Abstract][Full Text] [Related]
34. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding.
Nosanchuk JD; Casadevall A
Infect Immun; 1997 May; 65(5):1836-41. PubMed ID: 9125569
[TBL] [Abstract][Full Text] [Related]
35. Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule.
Ibrahim AS; Filler SG; Alcouloumre MS; Kozel TR; Edwards JE; Ghannoum MA
Infect Immun; 1995 Nov; 63(11):4368-74. PubMed ID: 7591072
[TBL] [Abstract][Full Text] [Related]
36. Binding of cryptococcal polysaccharide to Cryptococcus neoformans.
Kozel TR; Hermerath CA
Infect Immun; 1984 Mar; 43(3):879-86. PubMed ID: 6365785
[TBL] [Abstract][Full Text] [Related]
37. Expression of capsule-associated genes of Cryptococcus neoformans.
Okabayashi K; Kano R; Watanabe S; Hasegawa A
Mycopathologia; 2005 Aug; 160(1):1-7. PubMed ID: 16160761
[TBL] [Abstract][Full Text] [Related]
38. Cryptococcus neoformans capsule biosynthesis and regulation.
Janbon G
FEMS Yeast Res; 2004 Sep; 4(8):765-71. PubMed ID: 15450183
[TBL] [Abstract][Full Text] [Related]
39. Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans.
Mody CH; Syme RM
Infect Immun; 1993 Feb; 61(2):464-9. PubMed ID: 8423074
[TBL] [Abstract][Full Text] [Related]
40. Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages.
Ikeda-Dantsuji Y; Ohno H; Tanabe K; Umeyama T; Ueno K; Nagi M; Yamagoe S; Kinjo Y; Miyazaki Y
J Infect Chemother; 2015 Dec; 21(12):831-6. PubMed ID: 26477011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
